NCT07799740

Brief Summary

This multicentre feasibility study evaluates the feasibility of performing laparoscopic Laser Speckle Contrast Imaging (LSCI) measurements of rectal perfusion during rectal cancer surgery. To our knowledge, LSCI has not previously been applied laparoscopically for intraoperative assessment of rectal perfusion in this setting. Laparoscopic LSCI measurements will be compared with indocyanine green fluorescence imaging, and associations between quantitative measures of colorectal perfusion and postoperative outcomes, including anastomotic leakage, will be explored.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
32mo left

Started Sep 2026

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
Sep 2026Jun 2029

First Submitted

Initial submission to the registry

August 13, 2026

Completed
19 days until next milestone

Study Start

First participant enrolled

September 1, 2026

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 2, 2026

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2029

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2029

Last Updated

September 11, 2026

Status Verified

August 1, 2026

Enrollment Period

2.7 years

First QC Date

August 13, 2026

Last Update Submit

September 8, 2026

Conditions

Keywords

Laser speckle contrast imagingRectal cancerTotal Mesorectal ExcisionIndocyanine Green Fluorescent Imaging

Outcome Measures

Primary Outcomes (3)

  • Technical feasibility of intraoperative microcirculation assessment using PerfusiX-Imaging

    Feasibility is considered demonstrated if time spent on PerfusiX-Imaging measurements is ≤ 5% of total operating time and no more than two measurements are required to obtain a sufficient assessment of intestinal microcirculation. Unit: Percentage of participants with succesful assessment

    Intraoperatively

  • Surgeon-reported acceptability of PerfusiX-Imaging

    Surgeons will assess the acceptability and performance of PerfusiX-Imaging using a predefined Likert-scale questionnaire. Feasibility will be considered demonstrated if \>80% of surgeons report a positive evaluation of PerfusiX-Imaging. A positive evaluation is defined as a Likert score of ≥ 4 on at least three of the four predefined evaluation questions. Unit: Percentage of surgeons with a positive evaluation

    intraoperatively

  • Potential impact of PerfusiX-Imaging on surgical decision making

    The distance between the marked oral transection line with and without the use of PerfusiX-Imaging given by the surgeon and an independent expert. Feasibility will be considered demonstrated if the transection line differs by ≥ 10 mm. Unit: milimetres (mm)

    Intraoperatively

Secondary Outcomes (8)

  • Comparison of surgeon-reported acceptability between PerfusiX-Imaging and ICG-FI

    Immediately after surgery

  • Absolute intestinal microcirculation

    Intraoperatively

  • Relative intestinal microcirculation

    Intraoperatively

  • Length of initial hospital stay after surgery

    From the end of surgery until initial hospital discharge, up to 30 days after surgery

  • Severity of postoperative complications according to the Clavien-Dindo classification

    30 days after surgery

  • +3 more secondary outcomes

Study Arms (1)

Intraoperative aided assessment of intestinal microcirculation

EXPERIMENTAL

Participants undergoing total mesorectal excision (TME) for rectal cancer will undergo intraoperative assessment of rectal perfusion using laser speckle contrast imaging (LSCI) and indocyanine green fluorescence imaging (ICG-FI). Four to six days after TME, all participants will undergo computed tomography (CT) with intravenous contrast and a rectal contrast enema to assess for anastomotic leakage. Participants must be older than 18 years of age and provide informed consent prior to inclusion.

Device: Laser speckle contrast imaging

Interventions

Investigated device: PerfusiX-Imaging, LIMIS Development B.V., The Netherlands ICG-FI: Verdye, 0.2 mg/kg, Firefly® fluorescence imaging PerfusiX-Imaging is used Intracorporally prior to anal specimen transection, extracoporally prior to oral speciamen transection, intracorporally assessing the free bowel ends prior to anastomotic formation. ICG-FI is applied intracorporally assessing the free bowel ends prior to anastomotic formation. Diagnostic imaging: All participants undergo computed tomography with intravenous contrast and a rectal contrast enema.

Intraoperative aided assessment of intestinal microcirculation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • Rectal cancer
  • Surgical strategy either partial or total mesorectal excision
  • Able to provide informed consent

You may not qualify if:

  • \- Allergy to iodine

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Regional Hospital Gødstrup

Herning, Denmark

Location

Sygehus Lillebælt, Vejle Hospital

Vejle, Denmark

Location

Related Publications (17)

  • Danish Colorectal Cancer Group, DCCG Årsrapport 1. januar 2023 - 31. december 2023.

    RESULT
  • Power SP, Moloney F, Twomey M, James K, O'Connor OJ, Maher MM. Computed tomography and patient risk: Facts, perceptions and uncertainties. World J Radiol. 2016 Dec 28;8(12):902-915. doi: 10.4329/wjr.v8.i12.902.

  • Axt S, Haller K, Wilhelm P, Falch C, Martus P, Johannink J, Rolinger J, Beltzer C, Axt L, Konigsrainer A, Kirschniak A. Early postoperative endoscopic evaluation of rectal anastomoses: a prospective cross-sectional study. Surg Endosc. 2022 Dec;36(12):8881-8892. doi: 10.1007/s00464-022-09323-6. Epub 2022 May 23.

  • Valentin J; International Commission on Radiation Protection. Managing patient dose in multi-detector computed tomography(MDCT). ICRP Publication 102. Ann ICRP. 2007;37(1):1-79, iii. doi: 10.1016/j.icrp.2007.09.001.

  • Bowen DJ, Kreuter M, Spring B, Cofta-Woerpel L, Linnan L, Weiner D, Bakken S, Kaplan CP, Squiers L, Fabrizio C, Fernandez M. How we design feasibility studies. Am J Prev Med. 2009 May;36(5):452-7. doi: 10.1016/j.amepre.2009.02.002.

  • Heuvelings DJI, Al-Taher M, Calon J, Chand M, Stassen LPS, Lubbers T, Wevers KP, Boni L, Bouvy ND, Heeman W. Real-time intestinal perfusion assessment for anastomotic site selection using laser speckle contrast imaging: Verification in a porcine model. Surg Open Sci. 2025 Apr 18;26:12-17. doi: 10.1016/j.sopen.2025.04.007. eCollection 2025 Jun.

  • Hirst A, Philippou Y, Blazeby J, Campbell B, Campbell M, Feinberg J, Rovers M, Blencowe N, Pennell C, Quinn T, Rogers W, Cook J, Kolias AG, Agha R, Dahm P, Sedrakyan A, McCulloch P. No Surgical Innovation Without Evaluation: Evolution and Further Development of the IDEAL Framework and Recommendations. Ann Surg. 2019 Feb;269(2):211-220. doi: 10.1097/SLA.0000000000002794.

  • Heeman W, Steenbergen W, van Dam G, Boerma EC. Clinical applications of laser speckle contrast imaging: a review. J Biomed Opt. 2019 Aug;24(8):1-11. doi: 10.1117/1.JBO.24.8.080901.

  • Coraci MM, Schouw HM, Kruijff S, Mao Y, Noltes ME, Heeman W. Comparison of quantitative laser speckle contrast and indocyanine green imaging for intestinal perfusion measurements in robot assisted surgery. Sci Rep. 2025 Jul 1;15(1):21664. doi: 10.1038/s41598-025-05496-x.

  • Heeman W, Calon J, van der Bilt A, Pierie JEN, Pereboom I, van Dam GM, Boerma EC. Dye-free visualisation of intestinal perfusion using laser speckle contrast imaging in laparoscopic surgery: a prospective, observational multi-centre study. Surg Endosc. 2023 Dec;37(12):9139-9146. doi: 10.1007/s00464-023-10493-0. Epub 2023 Oct 9.

  • Paramasivam R, Jaensch C, Madsen AH, Orntoft MW. Intraoperative assessment of anastomotic microcirculation during right hemicolectomy with real-time laser speckle contrast imaging is safe and feasible. Colorectal Dis. 2025 Jul;27(7):e70162. doi: 10.1111/codi.70162.

  • Faber RA, Meijer RPJ, Droogh DHM, Jongbloed JJ, Bijlstra OD, Boersma F, Braak JPBM, Meershoek-Klein Kranenbarg E, Putter H, Holman FA, Mieog JSD, Neijenhuis PA, van Staveren E, Bloemen JG, Burger JWA, Aukema TS, Brouwers MAM, Marinelli AWKS, Westerterp M, Doornebosch PG, van der Weijde A, Bosscha K, Handgraaf HJM, Consten ECJ, Sikkenk DJ, Burggraaf J, Keereweer S, van der Vorst JR, Hutteman M, Peeters KCMJ, Vahrmeijer AL, Hilling DE. Indocyanine green near-infrared fluorescence bowel perfusion assessment to prevent anastomotic leakage in minimally invasive colorectal surgery (AVOID): a multicentre, randomised, controlled, phase 3 trial. Lancet Gastroenterol Hepatol. 2024 Oct;9(10):924-934. doi: 10.1016/S2468-1253(24)00198-5. Epub 2024 Aug 13.

  • Mc Entee PD, Singaravelu A, Boland PA, Moynihan A, Creavin B, Cahill RA. Impact of indocyanine green fluorescence angiography on surgeon action and anastomotic leak in colorectal resections. A systematic review and meta-analysis. Surg Endosc. 2025 Mar;39(3):1473-1489. doi: 10.1007/s00464-025-11582-y. Epub 2025 Feb 3.

  • Fang C, Nie P, Jing P, Zhang Y, Yang L, Yu Y, Wang C, Zhou Z. Effects of Adjuvant Therapy Compliance and Anastomotic Leakage on the Oncologic Outcomes of Patients With Rectal Cancer After Curative Resection. Dis Colon Rectum. 2021 Jun 1;64(6):689-696. doi: 10.1097/DCR.0000000000001824.

  • Gielen AHC, Heuvelings DJI, Sylla P, van Loon YT, Melenhorst J, Bouvy ND, Kimman ML, Breukink SO; CoReAL Collaborative. Impact of Anastomotic Leakage After Colorectal Cancer Surgery on Quality of Life: A Systematic Review. Dis Colon Rectum. 2025 Feb 1;68(2):154-170. doi: 10.1097/DCR.0000000000003478. Epub 2024 Oct 23.

  • Wang S, Liu J, Wang S, Zhao H, Ge S, Wang W. Adverse Effects of Anastomotic Leakage on Local Recurrence and Survival After Curative Anterior Resection for Rectal Cancer: A Systematic Review and Meta-analysis. World J Surg. 2017 Jan;41(1):277-284. doi: 10.1007/s00268-016-3761-1.

  • Hernandez PT, Paspulati RM, Shanmugan S. Diagnosis of Anastomotic Leak. Clin Colon Rectal Surg. 2021 Nov 23;34(6):391-399. doi: 10.1055/s-0041-1735270. eCollection 2021 Nov.

MeSH Terms

Conditions

Rectal Neoplasms

Interventions

Laser Speckle Contrast Imaging

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal Diseases

Intervention Hierarchy (Ancestors)

Optical ImagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisInvestigative Techniques

Central Study Contacts

Mai-Britt W. Ørntoft, MD, Ph.D, Ass. Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
This is an open-label trial. Participants, surgeons, and other study personnel are aware of the study procedures. However, the LSCI measurements are not available to the surgeons during the surgical procedure and are only revealed after completion of the surgery. Therefore, the LSCI measurements cannot influence the surgeons' intraoperative decision-making regarding creation of the rectal anastomosis.
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: The primary objective of this clinical investigation is to assess the feasibility of performing laparoscopic laser speckle contrast imaging (LSCI) measurements of intestinal perfusion during rectal cancer surgery. Feasibility will be evaluated in terms of technical feasibility, usability and acceptability among surgeons, and potential influence on surgical decision-making. Secondary objectives include comparison of LSCI with indocyanine green fluorescence imaging, assessment of quantitative perfusion measurements, and exploration of associations between perfusion measurements and postoperative outcomes.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 13, 2026

First Posted

September 2, 2026

Study Start

September 1, 2026

Primary Completion (Estimated)

May 1, 2029

Study Completion (Estimated)

June 1, 2029

Last Updated

September 11, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared. Identifiable personal data will not be disclosed to third parties.

Locations